Max
08-10-2001, 10:37 AM
Leading Spine Surgeons, Researchers Available for Opinion on
Bush Decision on Fate of Federal Funding for Stem Cell Research
To: National Desk
Contact: Terre Hall, 703-724-4176 or 703-973-0519 (cell);
e-mail: terre@mcfillenhall.com; or
Pamela Krueger, 708-588-8082,
both of the North American Spine Society
News Advisory:
Experts from the North American Spine Society (NASS), the nation's
leading multidisciplinary organization that focuses solely on
research, education and advocacy related to quality spine care and a
vocal presence in the current debate over federal funding for stem
cell research, are available today to provide comment and insight as
President Bush has made his decision whether to move forward with
federal funding for stem cell research.
Representatives from NASS can provide answers to several key
questions, including, but not limited to:
-- What exactly is a "stem cell" and how do researchers obtain
them?
-- Why is stem cell research so important, specifically to spinal
cord injury?
-- What is the difference between embryonic stem cells and adult
stem cells? Why aren't adult stem cells as useful as embryonic stem
cells?
-- Is there research currently being done using embryonic stem
cells?
-- What will happen to medical research in the United States if
President Bush halts federal funding for stem cell research?
What:
Analysis and comment on President Bush's decision on federal
funding for stem cell research.
When:
Available immediately.
Contact:
Terre Hall at 703-724-4176 or 703-973-0519 or Pamela Krueger
708-588-8082 to schedule an interview with a NASS member.
------
The North American Spine Society (NASS) is a non-profit,
multidisciplinary organization that advocates quality spine care
through education, research and advocacy. NASS comprises more than
30 different specialties including orthopaedic surgeons,
neurosurgeons, physiatrists, neurologists, radiologists,
anesthesiologists, physical therapists and other spine care
professionals.
KEYWORDS:
GOVERNMENT, HEALTH, POLICY
-0-
/U.S. Newswire 202-347-2770/
08/09 13:33
Copyright 2001, U.S. Newswire
Bush Decision on Fate of Federal Funding for Stem Cell Research
To: National Desk
Contact: Terre Hall, 703-724-4176 or 703-973-0519 (cell);
e-mail: terre@mcfillenhall.com; or
Pamela Krueger, 708-588-8082,
both of the North American Spine Society
News Advisory:
Experts from the North American Spine Society (NASS), the nation's
leading multidisciplinary organization that focuses solely on
research, education and advocacy related to quality spine care and a
vocal presence in the current debate over federal funding for stem
cell research, are available today to provide comment and insight as
President Bush has made his decision whether to move forward with
federal funding for stem cell research.
Representatives from NASS can provide answers to several key
questions, including, but not limited to:
-- What exactly is a "stem cell" and how do researchers obtain
them?
-- Why is stem cell research so important, specifically to spinal
cord injury?
-- What is the difference between embryonic stem cells and adult
stem cells? Why aren't adult stem cells as useful as embryonic stem
cells?
-- Is there research currently being done using embryonic stem
cells?
-- What will happen to medical research in the United States if
President Bush halts federal funding for stem cell research?
What:
Analysis and comment on President Bush's decision on federal
funding for stem cell research.
When:
Available immediately.
Contact:
Terre Hall at 703-724-4176 or 703-973-0519 or Pamela Krueger
708-588-8082 to schedule an interview with a NASS member.
------
The North American Spine Society (NASS) is a non-profit,
multidisciplinary organization that advocates quality spine care
through education, research and advocacy. NASS comprises more than
30 different specialties including orthopaedic surgeons,
neurosurgeons, physiatrists, neurologists, radiologists,
anesthesiologists, physical therapists and other spine care
professionals.
KEYWORDS:
GOVERNMENT, HEALTH, POLICY
-0-
/U.S. Newswire 202-347-2770/
08/09 13:33
Copyright 2001, U.S. Newswire